If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Edison issues initiation on De La Rue (DLAR)

14 Jan 2019 14:20

Edison Investment Research Limited Edison issues initiation on De La Rue (DLAR) 14-Jan-2019 / 14:19 GMT/BST


London, UK, 14 January 2019

Edison issues initiation on De La Rue (DLAR)

De La Rue (DLAR) continues to pursue a strategy that is transitioning the company to a less capital-intensive operation with a more diverse customer base and revenue streams, incorporating more embedded technology and IP. Underlying progress is apparent although masked by the disposals and the recent loss of the UK passport contract. The strengthening of the balance sheet enables appropriate M&A to augment what we expect to be a resumption of organic sales growth from FY21. The current rating implies scepticism but this should improve as growth prospects are recognised. In the meantime, the healthy dividend yield provides support for investors.

Our fair value DCF returns a value of 639p a share, a healthy 49% premium to the current share price. The implied P/E for FY20e of 13.9x is hardly demanding compared to the support services segment calendar 2019 P/E multiple of 14.8x. In our view, the current rating of 9.7x FY20 EPS with a yield of 5.8% does not reflect growth potential.Click here to view the full report.

All reports published by Edison are available to download free of charge from its websitewww.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Andy Chambers, +44 (0)20 3681 2525industrials@edisongroup.comLearn more at www.edisongroup.com and connect with Edison on:LinkedIn https://www.linkedin.com/company/edison-investment-research Twitter www.twitter.com/Edison_Inv_ResYouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

765863 14-Jan-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
8th Jul 20212:43 pmRNSDirector/PDMR Shareholding
6th Jul 20212:51 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSBlock listing Interim Review
1st Jul 20214:21 pmRNSTotal Voting Rights
1st Jul 20218:00 amRNSDirector/PDMR Shareholding
28th Jun 20213:55 pmRNSHolding(s) in Company
24th Jun 202111:24 amRNSHolding(s) in Company
18th Jun 20211:44 pmRNSAnnual Financial Report
1st Jun 202111:23 amRNSTotal Voting Rights
26th May 20217:00 amRNS2020/21 Full Year Results
13th May 20217:00 amRNSAUTHENTICATION CONTRACT WINS
4th May 20212:07 pmRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20217:00 amRNSTotal Voting Rights
23rd Mar 20215:09 pmRNSHolding(s) in Company
23rd Mar 20217:00 amRNSDirectorate Change
1st Mar 202112:20 pmRNSTotal Voting Rights
1st Feb 202112:37 pmRNSTotal Voting Rights
28th Jan 202112:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Statement
5th Jan 20219:36 amRNSDirector/PDMR Shareholding
4th Jan 202111:15 amRNSBlock listing Interim Review
4th Jan 202111:12 amRNSTotal Voting Rights
23rd Dec 202012:10 pmRNSDirector/PDMR Shareholding
1st Dec 20202:25 pmRNSTotal Voting Rights
1st Dec 20209:10 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNS2020/21 HALF YEAR RESULTS
4th Nov 20201:45 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSEXTENSION OF THE BANK OF ENGLAND CONTRACT
21st Oct 202011:32 amRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
1st Oct 20201:30 pmRNSTotal Voting Rights
1st Oct 20207:00 amRNSChief Financial Officer Appointment
22nd Sep 20207:00 amRNSDirectorate Change
1st Sep 202012:14 pmRNSTotal Voting Rights
24th Aug 20203:05 pmRNSHolding(s) in Company
13th Aug 20207:00 amRNSAppointment of Joint Broker
7th Aug 20204:42 pmRNSHolding(s) in Company
6th Aug 202012:40 pmRNSResult of AGM
6th Aug 20207:00 amRNSAGM Statement
4th Aug 20209:37 amRNSHolding(s) in Company
31st Jul 20203:52 pmRNSTotal Voting Rights
27th Jul 20207:00 amRNSAdditional Listing
22nd Jul 20206:00 pmRNSHolding(s) in Company
16th Jul 20205:12 pmRNSDirector/PDMR Shareholding
15th Jul 20204:13 pmRNSHolding(s) in Company
14th Jul 20203:03 pmRNSHolding(s) in Company
14th Jul 20202:40 pmRNSHolding(s) in Company
13th Jul 20203:18 pmRNSNotice of AGM
13th Jul 20203:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.